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1. HYDROGELS 
Gels are semisolid, viscoelastic systems containing dispersion of inorganic or organic molecule 
which entraps the solvent mobility. 
 Hydrogel is defined as the water swollen colloidal gel in which the liquid ingredient is water. 
These are three dimensional structures in which the polymer gets swollen upon imbibitions of 
large amount of water. Hydrogel allows free diffusion of some molecules and the polymer act as 
a matrix to hold water together. Hydrogels can absorb water or other biofluids with some being 
able to swell[1]. The property of hydrogel includes pore size, fabrication techniques, shape and 
surface/volume ratio, H2O content, strength and swelling activation. Due to significant water 
content in the hydrogel structure it shows the degree of flexibility. 
Hydrogels are having different form of structure[2].  Hydrogels structures are of three types 
macroporous, microporous and non-porous[3]. 
                                                         Gels/Hydrogels 
 
                        Physical                                                             Chemical 
 
       Strong                          Weak             Condensation           Addition           Cross-linking 
There are two types of hydrogels physical and chemical. 
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1.1. Physical Hydrogel 
Physical hydrogels (PHs) are thermoreversible gel networks made of molecular rearrangement 
and secondary forces including hydrophobic interactions. It is categorized in to two types strong 
and weak. Strong gel includes glassy nodules, lamellar microcrystals and double/triple helices.  
Example includes elastomers / block copolymers and gelatin. Weak gels are due to   hydrogen 
bonds, ionic and hydrophobic associations. Example includes xanthan, paint and matured acacia 
gum etc[4-5] 
 1.2. Chemical Hydrogel 
When the gels are covalently cross-linked it is called as chemical hydrogel. They are also termed 
as permanent hydrogel. The crosslinking density and the polymer-water interface are responsible 
for maintaining the swelling state symmetry of the hydrogels.  Chemical hydrogel can be formed 
by the addition of critical percolation for example polyester gel, also from condensation for 
example polyester gel and form crosslinking[6-7].                                                                             
2. CLASSIFICATION OF HYDROGELS 
There are generally two types of hydrogels. 
a. Natural hydrogels 
b. Synthetic hydrogels 
2. a. Natural hydrogels  
Natural hydrogels are existing naturally in the environment. These are the material being 
inspected for articular tissue engineering. The polymer used in the natural hydrogels are natural 
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hydrogels are gelatin, methyl cellulose, alginate, agarose/agar, fibrin, chitosan, hyaluronan, 
chondroitin sulfate and other naturally derived polymers.                        
Advantages 
Due to the excellent biocompatibility natural hydrogels used for tissue engineering application. 
Natural hydrogels are also having different application like they are low poisonous byproducts, 
intrinsic cellular interactions and biodegradable in nature. 
Disadvantages 
The negative aspect of natural hydrogel includes variation of batch, low mechanical strength and 
the material derived from animal may pass on viruses. 
2. b. Synthetic hydrogels 
 Synthetic polymer hydrogels constitute a group of materials used in numerous biomedical 
disciplines and developing for new promising applications. These hydrogels are synthesized 
artificially. Manufacture microarrays and soft contact lens are produce from synthetic hydrogel 
polymers. Synthetic hydrogels have excellent mechanical properties. Synthetic hydrogels are 
made from protein-polymer adducts. The synthesis of hydrogels was performed through radical 
copolymerization. For some cases synthetic hydrogels can perform the task of natural 
hydrogel[8].The polymer used in the synthetic hydrogels are polyanhydrides, poly(aldehyde 
guluronate), Poly ethylene glycol etc. 
Advantages 
Synthetic hydrogels shows various biomedical applications like coating and in devices. These 
hydrogels are having very low immunogenicity and minimize the risk of biological impurities 
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Disadvantages 
They are having poisonous substances and low degradability.  
3. Application of Hydrogels  
Hydrogels are utilized naturally by the human body, for example cartilage, mucin, blood 
clots and vitreous humor of the eye. There is various of application Hydrogels like soft 
contact lenses, Pills/capsules, Bioadhesive carriers, Implant coatings, etc. 
3.1. Application of hydrogels in Drug Delivery Delivery 
Hydrogels are having various helpful applications in drug delivery and pharmaceutical sciences 
due to their large amount of water content. Hydrogels are mainly utilized for conventional 
controlled drug release system, bioactive materials etc. Hydrogel based drug delivery system can 
be used for various types like oral, ocular, conventional, epidermal and subcutaneous application. 
Hydrogels is the suitable medium for the drug delivery due to its biocompatibility, network 
structure. Hydrogels are also applicable gene delivery and subcutaneous delivery. 
3.2. Application of hydrogels in Tissue Engineering 
Hydrogels are three dimensional water swollen structures which is insoluble networks of 
crosslinked hydrophilic polymers. Hydrogels plays an important role in different tissue 
engineering application. Hydrogels have been used as scaffold materials for various purposes 
like tissue replacement, drug delivery, call and tissue delivery, bioactive molecule delivery, 
space filling agent and various other applications[9].  
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 3.3. Application of hydrogels in Biomedical Engineering 
Hydrogels have been effectively used in various biomedical applications due to its biocompatible 
and biodegradable nature[2, 10]. For the biomedical application most of the polymer used for 
cytotoxicity and in-vivo toxicity tests. The application of hydrogel in biomedical area contains 
Phospholipids bilayer, energy conversion system, mass transport properties etc. 
3.4. Application of hydrogels in Biomaterials 
Hydrogels have been used in various applications in biomaterials due to the biodegradable and 
bioadhesive nature. The example includes soft contact lenses, wound dressing and 
superabsorbent.  
3.5. Application of hydrogels in Agriculture 
Hydrogel have been used in various agricultural applications. The water holding capability of the 
soil increased when the hydrogels are added to the surface.  It also decreases the nutrient loss 
from the soil. Hydrogels are less efficient in the saline soil. Hydrogels can be applied directly in 
the soil or by spraying. 
4. Limitations 
The limitations of hydrogels includes high cost, Low mechanical strength, Difficult to load, 
Difficult to sterilize, can be hard to handle and Non adherent in nature. The limitation of using 
hydrogels for engineering tissue is poor in mechanical characteristics. Due to the low tensile 
potency   many   hydrogels limit their use in load bearing application and can result in flow away 
of  hydrogel  from a targeted local site[11-12]. 
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5. Gelatin 
Gelatin can be obtained from collagen of bones, ligaments and tendons. Due to the gelling agent 
gelatin can be used in various purposes like in pharmaceutical industry, food industry etc. 
Gelatin is having various application in food, biomedical and nutritional properties. Gelatin can 
be extracted from two processes acid process and alkaline process.  
5.1. Use of Gelatin 
The functional uses of gelatin include Stabilizer, gelling agent, emulsifying agent and 
crystallization inhibitor. Gelatin in a highly purified form is a fascinating substance for food and 
recognized to have thickening, jellifying, foaming, viscosity enhancing, binding, emulsifying, 
filming etc. It is used for its pharmaceutical, photographic and technical applications.  
The pharmaceutical industry uses very large quantities of gelatin for making hard and soft gel 
capsules. 
There are two types of gelatin Edible (e.g. Jello (gelatin + sucrose + flavor) & Knox (plain 
gelatin)) and Inedible (e.g. Glue, paste) 
5.2. Technical use 
Gelatin are having various technical use like in coating and sizing, Paper Manufacture, Printing 
Processes, Protective colloidal applications, matches, Coated Abrasives, Adhesives, Gelatin 
Films and Light Filters, Microencapsulation etc. 
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6. Application of Gelatin 
6.1. Food Industry 
It plays an important role in the food industry.Gelatin is also used as a binding and glazing agent 
in meat and aspics[13]. 
5.2. Pharmaceutical Health Industry 
In the pharmaceutical health industry, gelatin is highly digestible.  
5.3. Cosmeceuticals  
Gelatin has been used for many years in the cosmetics industry as in shampoos, conditioners and 
lipsticks etc. 
6. Manufacture of empty gelatin capsules 
Steps involving in making gelatin capsules are Dipping, Spinning, Drying, Stripping, Trimming 
and joining and Polishing. 
Crosslinkers are either homo or hetero bifunctional reagents with identical or non identical 
reactive groups. They can be covalent bonds or ionic bonds.  
 7. Genipin 
Genipin can be obtained from an iridoid glucoside, geniposide abundantly present in the fruit of 
Genipa Americana and Gadenia jasminoides. Gadenia jasminoides is an evergreen flowering 
plant of the family Rubiaceae. Iridioid compound is a large class of natural products generally 
present in plants. They are the source of yellow pigments traditionally used in East Asia for 
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dyeing textiles also edible blue pigment used in the food industry. The blue pigments are 
important because they are highly stable to heat, pH and light. Genipin was reacted with beta-LG 
to produce a new class of modified molecules[15]. The structure of the genipin was discovered in 
1960‟s by Djerassi and his colleagues. The molecular formula of genipin is C11H14O5. The molar 
mass of the genipin is 226.226 g/mol. Genipin and its derivatives have been used as an herbal 
medicine, biomedical products, tissue engineering application and a natural colorant in the food 
industry. Genipin has been widely used as antiphlogistic and a cholagogue in herbal medicine. 
Genipin is less toxic and degrades more slowly as compared to formaldehyde and 
glutaraldehyde. It has been reported that genipin bind with biopolymer like chitosan and gelatin.  
A dark blue color look was found when genipin crosslinked with gelatin. Time and 
polymer/genipin concentrations are the main two factors in genipin crosslinking reaction. 
Genipin also used in Cell encapsulation. Genipin is sparingly soluble in aqueous buffers. Genipin 
is being examined as new way of latent fingerprints on paper products forensic science. Recently 
genipin has come to attention in biomaterial industry. Chitosan and gelatin crosslinked with 
genipin has been reported to increase neuroblastoma cell adhesion and its proliferation. Genipin 
can be used as regulating agent in drug delivery. For the stability of genipin thin layer 
chromatography was used. Genipin exhibited significant topical anti-inflammatory effect and 
anti-angiogenic properties.  
Glutaraldehyde (GA) is an organic compound having chemical formula CH2(CH2CHO)2. GA is a 
pungent colorless oily liquid. GA is an aliphatic dialdehyde that undergoes most of the typical 
aldehyde reactions to form acetals, cyanohydrins, oximes, hydrazones and bisulfite complex.GA 
has found spread use for enzyme immobilization[16]. 
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                                                    Fig 3.(a) Genipin (b) Glutaraldehyde    
8.Emulsion 
Emulsion are defined as a thermodynamically unstable system which consist of two immiscible 
liquid phases which are converted in to a single liquid phase in the help of emulsifying agent. 
Emulsion can be delivered by oral, topical and parenteral routes. 
 
8.1.Water in oil emulsion (w/o) 
In the water in oil emulsion oil is the dispersion medium where the water is dispersed phase. In 
this process it is not depends on the water and oil ration rather depends on the type of 
emulsifier.Due to better water resistant it is used as the sun protective factor. It is generally 
choose for external use like cream. 
 
8.2. Oil in water emulsion (o/w) 
In the oil in water emulsion water is the dispersion medium where the oil is the dispersed 
phase.It is generally oily and not water soluble. Oil in water emulsion are having various use like 
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they are used in the adjuvants for the influenza vaccines. It is usually prefered because because it 
provide cooling when used externally for e.g. vanishing cream. 
 
8.3. Dilution Test 
It can be of two type‟s o/w emulsion diluted with water and w/o emulsion diluted with oil. 
8.4. Conductivity Test 
Continuous phase of water is greater than continuous phase in oil. 
8.5. Dye-Solubility Test 
Water soluble dye will dissolve in the aqueous phase. The oil soluble dye will dissolve in the oil 
phase. 
9. Application of Emulsion 
There are several of applications are there for emulsion like oily drugs are prepared in form of 
emulsion. In the metallurgical method the concentration of ore by forth floatation process is 
based upon the treatment of the powdered ore in the emulsion. Milk is an emulsion of liquid fats 
in water. The cleaning action is based upon the formation of oil-in-water emulsion.  
10. Starch 
Starch is a natural, low-priced, obtainable, renewable, and biodegradable polymer produced by 
many plants as a source of stored energy. It is the most rich storage polysaccharide in plants and 
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described  as, pulse and tubers. A glycosidic bond joins the glucose moieties of starch. Amylase 
and amylopectin are the two main composition of starch [17]. 
10.1. Amylose 
Amylase is a linear polymer generally made of D-glucose unit. This polysaccharide is one of the 
two main components of starch. Which make up 20-30% of the structure.  Amylose normally 
contributes to gelling characterstics. 
10.2. Amylopectin 
Amylopectin is a soluble polysaccharide and highly branched polymer of glucose found in 
plants. Glucose units are linked with α glycosidic bond. It formulates 70-80% of the structure. 
Amylopectin normally contributes to thickening agent. 
Corn Starch 
Corn starch is obtained from the corn (maize grain). The corn plant converted large amount of 
radiant energy in to stable chemical energy. Corn starch is having various uses like thickening 
agent in foods for e.g. soup and sauces etc.  
Soluble starch 
Soluble starch is defined as a high molecular weight water soluble dextrin   manufactured by 
partial hydrolysis of starch. It is white amorphous powder. It is quite dispersible in hot water.  
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Use of Starch 
Starch is having several of use like in Beverages, Confectionery, Bakery products, Chocolate, 
Processed foods, Desserts & Dairy, Paper & Board, Pharmaceutical & Cosmetics, Aqua feed, 
Animal feed, Pet food and in various industrial applications.           
16. Application of starch 
Starch and its modified counter parts have found its wider applicability in food and non-food 
modified starches have a wide variety of use both in the food and non food vicinities. The major 
application of starches lies in pharmaceuticals, food and cosmetics industry. Starch plays an 
increasing role in the field of biodegradable plastics, packaging material, printed circuit boards, 
dry cell batteries and moulds. Starch is used as an adhesive for example hot-melt glues, stamps, 
bookbinding, envelopes, wood adhesive, lamination, automotive, corrugation and paper 
sacks[18].  
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Abstract 
The present study discusses about the development and characterization of genipin-crosslinked 
gelatin based emulsion hydrogels (EHs). EHs were prepared by varying the proportions of 
gelatin solution and mustard oil. Both the uncrosslinked (uEHs) and the crosslinked (cEHs) gels 
were characterized thoroughly by microscopy. The microscopic results suggested that the 
internal phase droplet size distribution was broader for gels with higher proportions of oil. 
Thermal properties of the gels were found to be affected by both gelatin and mustard oil 
proportions. The gels were loaded with ciprofloxacin (CF, model drug). The pHs of the gels were 
within the limits of the pH of the human skin. The gels were hemocompatible and tried as a 
carrier for controlled drug delivery. 
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1. Introduction 
Gels are defined as 3D polymeric networked structures having the ability to undergo extensive 
swelling when immersed in proper solvent [19-22]. If the absorbed solvent is aqueous in nature, 
the gel is regarded as hydrogel. The swelling properties of the hydrogels may be tailored by 
changing the crosslinking density of the polymeric matrix. Since the diffusion of the drug 
molecules are dependent on the amount of physiological solution present within the matrices, 
altering the crosslinking density of the matrix has been found to modulate the release properties 
of the bioactive agents [23]. Various biopolymers (e.g. gelatin, chitosan, alginate, celluloses and 
collagen) have been used for the designing of the hydrogels for pharmaceutical applications [23-
30]. Gelatin is a protein based biopolymer, which is derived from animal collagen. It is a highly 
biocompatible biopolymer and hence has been used in the development of various 
pharmaceutical products [23, 31-33].  
Mustard oil (MO) MO has been traditionally extensively used in the southern Asian countries 
(India, Pakistan and Bangladesh) for the skin massages of infants and adults [34-36]. Apart from 
this, MO containing emulsions have been developed for the topical ocular delivery of non-
steroidal anti-inflammatory drugs (NSAIDs) viz., diclofenac [37]. In recent years, MO has been 
used as an adjuvant for the development of novel new nutritive-immune enhancing delivery 
system [38-39]. Taking inspiration from the above studies, MO was used as the representative 
oil. 
In the current study, attempts were made to develop genipin crosslinked mucoadhesive gelatin 
EHs as a matrix for controlled delivery of antimicrobials. EHs may be defined as the hydrogel 
based matrix system in which an oil has been distributed uniformly [40-41]. Genipin is a 
naturally occurring crosslinker obtained from the fruits of Gardenia jasminoides. It has been 
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gaining importance in biomedical industries due to its far less cytotoxic nature as compared to 
glutaraldehyde [42-44]. The developed gelatin based EHs were studied for their suitability as 
dermal/transdermal drug delivery systems. 
2. Materials and methods 
2.1. Materials 
Tween 80 (polyxyethylene sorbitan monooleate), gelatin and glycine were procured from 
Himedia, Mumbai, India. Ciprofloxacin (CF) was procured from Fluka Biochemica, China. 
Sodium citrate was procured from Loba Chemie, Mumbai, India. Genipin was procured from 
Challenge Bioproduct Company Limited, China. Mustard oil (MO) was purchased from local 
market. Goat intestine and blood were collected from the local butcher shop. Double distilled 
water (DW) was used throughout the study. 
2.2. Preparation of EHs 
The EHs were prepared as per the method reported earlier with slight modifications in the 
procedure [40]. In short, twenty percent (w/w) gelatin solution was prepared by dissolving 20 g 
of gelatin in 80 g of DW, kept on stirring at 50 °C (GS). To this clear homogenous solution, 2 ml 
of Tween 80 was added. MO, maintained at 50 °C, was added to GS and homogenized at 800 
rpm for 15 min to form primary emulsion (PE). 0.1 g of genipin was added to the PE and further 
homogenized for 30 sec. The emulsion was subsequently poured into petri-plates and incubated 
at 40 
o
C for 30 min to promote crosslinking of the gelatin matrix. Excess genipin was neutralized 
by 1% (w/w) glycine solution [22]. The crosslinked gels were washed thoroughly with DW and 
stored under refrigerated conditions (5 °C). These gels were regarded as cEHs. CF loaded EHs 
were prepared in a similar manner by using 1% (w/v) CF solution in MO as the internal phase. In 
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the similar manner, uncrosslinked EHs (uEHs) were prepared by pouring the PEs into perti-
plates and subsequent incubation at 4 °C for 30 min. The gels were stored under refrigerated 
conditions for further analysis. 
2.3. Microscopic evaluation of the gels  
The microstructures of the molten uEH gels were studied under compound bright-field 
microscope (Leica-DM750 equipped with ICC 50-HD camera, Germany). The droplet size 
distribution of the emulsions was analyzed using NI vision assistant-2010 (USA) software as per 
the reported literature [45].  
2.4. Thermal studies 
The melting points of the uncrosslinked gels (uEHs) were analyzed by falling ball method, as per 
the reported method [46]. In short, a stainless steel (SS) ball (diameter 1/8 inch and weight 130 
mg) was put over the 2 g formulation, kept in a 10 ml test-tube under refrigeration. The gels were 
heated at a rate of 1 °C/min. The temperature at which the SS ball is completely submerged into 
the formulation was noted as the melting point (Tm) of the gels. 
2.5. Swelling behavior 
The swelling behaviors of the cEHs were determined as per the reported literature. In short, 
accurately weighed (Wo) gels were incubated in a beaker containing 100 ml of DW at RT [47]. 
At regular intervals of time (15 min for the first 1h and thereafter 30 min up to 8h), the EHs were 
taken out. The surface bound water was removed by wiping with a tissue paper. The weights of 
the cEHs were accurately measured using a digital weighing balance (Wt). Swelling ratio (SR) of 
the EHs was calculated as per the formula given in equation 1 [47]. 
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0
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W
WW
SR t


     (1) 
Where, SR=swelling ratio 
Wt is the weight of the swollen gel at time t. 
W0 is the initial gel weight 
2.6. pH measurement 
The pHs of the uEHs and cEHs were measured using a digital pH meter (Model 132E, EI 
products, Mumbai, India) as per the reported literature [48]. 
2.7. Hemocompatibility test 
The hemocompatibility test was done as per the ASTM protocol described in the previous 
literature [22, 28-29, 31-32, 49-53]. The % hemolysis of the blood was calculated as per the 
equation 2. 
% 100
test Negative
positive Negative
OD OD
Hemolysis
OD OD

 

   (2) 
Where, 
ODtest = Absorbance of test sample, 
ODpositive = Absorbance of positive control and  
ODnegative = Absorbance of negative control.
 
2.8. In vitro drug release studies 
In vitro drug delivery studies of uEHs were performed using modified Franz diffusion cell [54]. 
1.5 g (approx) of the uEHs were weighed accurately and kept into the donor chamber of the 
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diffusion cell. The donor and receptor chambers were separated by a dialysis membrane. The 
receptor volume was maintained at 50 ml throughout the study. During the study, sampling was 
done at every 15 min during first hour and subsequently at every 30 min in the next 7h. During 
each sampling, the whole receptor medium was replaced with the fresh medium (DW). At the 
end of the study, the samples were analyzed for the presence of CF at 271 nm using UV-visible 
spectrophotometer (UV-3200, LABINDIA, Mumbai, India). 
The drug dissolution tests of the cEHs were carried out in single basket dissolution apparatus for 
8 h. Accurately weighed 1.5 g (approx) of EHs were cut. The drug containing EHs were put into 
the dissolution basket containing 900 ml of DW. The speed of the stirrer was kept at 100 ± 2 rpm 
and the dissolution medium temperature was maintained at 37 ± 2 °C. 3 ml of samples were 
withdrawn at regular intervals of time (15 min for the first hour and 30 min for the next 7 h). 
Fresh dissolution medium of same volume was replaced after each sampling. The samples were 
analyzed at 271 nm using UV-visible spectrophotometer. 
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3. Results and discussion 
3.1. Preparation of EHs 
The EHs were prepared by varying the proportions of gelatin solution and oil. The compositions 
of the gels have been tabulated in table 1. The blank gelatin gel was light brown in color and was 
translucent. The uEHs were yellowish in color due to the yellow color of the MO. There was an 
increase in the yellowish tinge of the uEHs as the proportion of MO was increased in the gels 
(Fig. 1). On the other hand, cEHs were found to be dark blue color (Fig. 2), a characteristic color 
produced due to the reaction of the primary amino groups and genipin [55-56]. The color of the 
cEHs was dependent on the composition of the gels [57]. With the increase in the proportion of 
the MO in the cEHs, there was subsequent increase in the dark blue color due to higher 
crosslinking density of the gelatin matrices. Both types of the EHs had a smooth texture and 
were opaque. There were no changes in the textural properties of the gels (uEHs and cEHs) after 
the addition of 1 % (w/w) CF drug. All the drug containing formulations were found to be stable. 
                                    Table1: Composition of the prepared gels 
Samples Volume of 20 % (w/v) 
gelatin solution (ml) 
Volume of 
MO (ml) 
Genipin 
(g) 
Ciprofloxacin 
(% w/w) 
Result 
uG1 20.0 0 -- -- Gel formed 
uG2 17.5 2.5 -- -- Gel formed 
uG3 15.0 5.0 -- -- Gel formed 
uG4 12.5 7.5 -- -- Gel formed 
uG5 10.0 10.0 -- -- Gel formed 
cG1 20.0 0 0.1 -- Gel formed 
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cG2 17.5 2.5 0.1 -- Gel formed 
cG3 15.0 5.0 0.1 -- Gel formed 
cG4 12.5 7.5 0.1 -- Gel formed 
cG5 10.0 10.0 0.1 -- Gel formed 
uG1D 20.0 0 -- 1.0 Gel formed 
uG2D 17.5 2.5 -- 1.0 Gel formed 
uG3D 15.0 5.0 -- 1.0 Gel formed 
uG4D 12.5 7.5 -- 1.0 Gel formed 
uG5D 10.0 10.0 -- 1.0 Gel formed 
cG1D 20.0 0 0.1 1.0 Gel formed 
cG2D 17.5 2.5 0.1 1.0 Gel formed 
cG3D 15.0 5.0 0.1 1.0 Gel formed 
cG4D 12.5 7.5 0.1 1.0 Gel formed 
cG5D 10.0 10.0 0.1 1.0 Gel formed 
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Fig. 1: uEHs of different compositions (a) uG1, (b) uG2, (c) uG3, (d) uG4 and (e) uG5 
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Fig. 2: cEHs of different compositions (a) cG1, (b) cG2, (c) cG3, (d) cG4 and (e) cG5 
 
3.2. Microscopic evaluation of the emulsions 
The micrographs of the molten uEHs have been shown in Fig. 3. The micrographs suggested the 
presence of dispersed circular MO droplets within the GS continuum phase. There was an 
increase in the size of the dispersed phase droplets with the increase in the MO proportion. The 
droplet size distribution of the internal phase in the gels followed Gaussian distribution (Fig. 4a). 
This type of distribution is achieved when physical methods are used for the preparation of the 
emulsions [58-59]. The sizes of the droplets were in the range of 10-30 µm. 50 % of the droplet‟s 
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population was having the size of 15 microns (approx) (Fig. 4b). The presence of narrow size 
distribution gives an indication of a probable stable emulsion [60].  
 
Fig. 3: Light micrographs of MO-in-gelatin sol emulsion. (a) uG1, (b) uG2, (c) uG3, (d) uG4 
and (e) uG5 gels. 
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Fig. 4: Droplets size distribution of uEHs, in terms of their (a) % frequency and (b) 
cumulative % frequency 
. 
3.3 Thermal studies 
The melting point (Tm) of the uEHs was determined by drop ball method as reported earlier 
(table 2) [46]. The Tm of the gels was found to be decreasing as the proportion of MO was 
increased. Higher Tm of uG1 may be due to the formation of strong physical polymeric network 
when gelatin molecules were dissolved in water. Incorporation of MO within the gelled structure 
resulted in the reduction of the intensity of the intermolecular hydrogen bonding which, in turn, 
caused reduction in the Tm. 
Table 2: The melting point values of uEHs by drop ball method 
Samples Tm (°C) 
uG1 32.10 ± 2.66 
uG2 31.20 ± 1.92 
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uG3 30.90 ± 2.44 
uG4 30.50 ± 3.32 
uG5 30.00 ± 2.26  
3.4. Swelling studies 
The swelling behaviour of the crosslinked gels have been shown in Fig. 5. The swelling 
behaviour was dependent on the MO content in the gels. The amount and rate of swelling of the 
gels were lower in gels with higher proportions of MO. This may be attributed to the lower 
amount of gelatin, which is responsible for the absorption of water. The structural integrities of 
the gels were intact during the swelling study.  
                                  
                                    Fig. 5: Swelling behavior of cEHs 
3.5. pH measurement 
The study of the pH of the pharmaceutical formulation is an important parameter. Various 
pharmacopoeia have set standards for the pharmaceutical formulations [61]. This is due to the 
reason that the formulations are meant to be in contact with the cells and tissues. Higher or lower 
pH values may cause irritation of chemical burn.  The results of the study have been tabulated in 
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table 3. The pH of the EHs was found to be in the range of 5.5 to 7.0. This suggested that the 
developed gels may be used for transdermal and topical formulations.  
Table 3: The pH of hydrogels 
Samples pH 
uGH1 5.60 ± 0.75 
uGH2 5.62 ± 0.81 
uGH3 6.00 ± 0.44 
uGH4 7.27 ± 0.82 
uGH5 5.80 ± 0.44 
cGH1 6.54 ± 0.23 
cGH2 6.81 ± 0.45 
cGH3 6.43 ± 0.62 
cGH4 6.75 ± 0.31 
cGH5 6.62 ± 0.13 
 
3.6. Hemocompatibility studies 
The % hemolysis of the goat blood in the presence of the leachants of the EHs was found to be 
below 5% (table 4) suggesting that the gels may be regarded as biocompatibile [62]. Henceforth, 
EHs may be tried as drug delivery vehicles. 
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Table 4: % hemolysis of the EHs 
Samples % Hemolysis 
uG1 2.60 ± 0.55 
uG2 2.19 ± 0.82 
uG3 1.10 ± 0.62 
uG4 0.68 ± 0.47 
uG5 0.41 ± 0.79 
cG1 3.82 ± 0.32 
cG2 2.86 ± 0.65 
cG3 1.50 ± 0.49 
cG4 1.36 ± 0.19 
cG5 0.68 ± 0.67  
 
3.7. In vitro drug release studies 
Fig. 6 shows the drug release profile of CF from uEHs and cEHs. The rate of drug release was 
found to be dependent on the physicochemical properties of the gels (e.g crosslinking density, % 
swelling and impedance). The higher amount of drug release may be associated with gels with 
higher % swelling and lower impedance. Higher % swelling leads to higher partition of the drug 
from gel matrix into the external aqueous phase. This resulted in higher CPDR value from the 
cG1 than the cG3 and cG5. This may be due to the partition coefficient effect of the drug, which 
states that the solute distributes itself amongst the two immiscible liquids in a definite 
concentration ratio [63-65]. Crosslinking of the gels decreased the net amount of drug release. 
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uEHs have higher cumulative % drug release (CPDR) than the cEHs. The lower CPDR from 
cEHs might be due to the hindrance of free movement of water within the cEHs. 
 
                     Fig. 6: In vitro CPDR profile of CF from (a) uEHs and (b) cEHs 
 
4. Conclusion 
The study reports the successful development of a novel gelatin-based EHs using genipin as 
crosslinking agent. MO was used as representative oil. The effect of proportion of internal oil 
phase on the properties of the gels was studied by various physical techniques. The amount of 
drug released was dependent on the oil proportion of the gels.  The study suggested that the rate 
of release of the drugs may be altered by altering the proportion of the internal oil phase. The 
gels were found to be biocompatible and may be used as matrices for the controlled drug 
delivery. 
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Development and characterization of gelatin-starch inclusion 
physical hydrogels 
 
 
 
 
 
 
 
 
 
                             CHAPTER 2 
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ABSTRACT 
The current study deals about the development and characterization of gelatin-starch based 
phase-separated hydrogels. The hydrogels were prepared using corn starch, soluble starch and 
boiled starch. The hydrogels were characterized by pH and thermal studies, Metronidazole (MZ), 
a model antimicrobial drug, was incorporated within the hydrogels. The hydrogels were highly 
hemocompatible in nature. All the samples were found to have pH in the range of 5.00-6.00. The 
Based on the preliminary results, it was concluded that the developed gels have a good potential 
to be used as carriers for bioactive agents. 
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1. Introduction 
Hydrogels are three-dimensional cross-linked networks of hydrophilic polymers [27, 66]. Due to 
this, hydrogels are able to imbibe and hold water within its structure, which in turn, results in the 
migration of water into the core of the polymeric construct. If drug is incorporated into the 
polymer construct, the absorption of water results in the dissolution of the drug molecules 
thereby creating a concentration gradient. This results in the diffusion of the drug molecules out 
of the polymer matrix. The rate of diffusion of the drug out of the hydrogel is dependent on the 
physical and chemical properties of the hydrogels. Depending on the nature of the hydrogels and 
how it alters the drug release profile, the hydrogels may be used either as matrices for controlled 
release or quick release systems [3, 40, 67]. Apart from the pharmaceutical industries, hydrogels 
have also been used extensively in food [68] and biomedical [69-71] industries. The wide spread 
usage of hydrogels is mainly due to their inherent biocompatible nature [72]. They may be made 
biodegradable, designed to support cellular activities [73] and protect cells [74]. The natural 
polymers used for the design/construction of hydrogels can be broadly categorized either as 
proteins (e.g. collagen [75] and gelatin [76]) or as polysaccharides (e.g. starch [77], alginate and 
agarose [78]).  
The crosslinking of the polymers to form hydrogels may either be due to physical interactions or 
chemical bond formation. Physical interactions include ionic crosslinking, hydrogen bonding and 
molecular entanglement, i.e. there is no formation of covalent bonds. Chemical crosslinking 
includes formation of covalent bonds during the formation of hydrogels [79]. The mechanical 
and thermal properties of the chemically crosslinked hydrogels are far better than the physically 
crosslinked hydrogels [79]. The primary disadvantage of the chemically crosslinked hydrogels is 
the presence of uncrosslinked starting materials which might cause undesirable side effects [79]. 
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Due to this reason, the physically crosslinked hydrogels have been extensively studied in food 
industries.  
Gelatin is a protein based biopolymer and is obtained by the hydrolysis of collagen from animal 
sources [80]. It is inherently biocompatible and biodegradable in nature [81]. It has been used 
extensively not only to develop food and pharmaceutical products but also various other products 
of biomedical importance [2, 40]. Starch, on the other hand, is a polysaccharide biopolymer [82]. 
Starch is one of the biopolymers of choice in food, pharmaceutical and biomedical industries. 
This is due to its abundance in nature, safe for human consumption and biodegradability [83]. 
Gelatin has been reported to form phase-separated hydrogels with polysaccharides like starch 
and maltodextrin [84-85]. This paper has been designed to study the effect of composition of the 
gelatin-starch phase-separated systems on the physical properties of the physical hydrogels. 
Apart from this, effects of different grades of starches (e.g. corn starch (CS), soluble starch (SS) 
and boiled starch (BS)) on the properties of the hydrogels were studied in-depth.  
2. Materials and methods 
2.1. Materials 
Gelatin, CS, sodium azide, nutrient agar and dialysis tubing (MW cutoff: 60 kDa) were 
purchased from Himedia, Mumbai, India. SS was purchased from Merck Specialties Private 
Limited, Mumbai, India. Hydrochloric acid (HCl) and sodium citrate were purchased from Loba 
Chemie, Mumbai, India. Ethanol was purchased from Changshu Yangyuan Chemical, China. 
Metronidazole (MZ) was a kind gift from Aarti drugs, Mumbai, India. Fresh goat blood was 
obtained from the local butcher shop. All the experiments were carried out using double distilled 
water (DW). 
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2.2. Preparation of the hydrogels 
Preparation of the suspensions and solutions: A clear homogeneous 20 % (w/w) solution of 
gelatin was prepared by dissolving 20 g of gelatin in 60 g of DW, kept on stirring at 50 °C. After 
the dissolution of the gelatin in the DW, the final volume was made to 100 g with DW 
maintained at 50 °C (GS). 
Three kinds of starches were used, viz. CS, SS and BS, for the development of the hydrogels.  2 
% (w/w) CS or SS dispersion was prepared by dispersing 2 g of CS or SS in 98 g of DW. BS 
dispersion was prepared by heating 2 % (w/w) of CS dispersion in DW at 80 °C for 30 min. The 
final weight of the suspension was made to 100 g using warm DW and subsequently cooled to 
room-temperature (RT, 25 °C). The above solutions and suspensions were used for the 
preparation of the hydrogels. 
Preparation of the hydrogels: Physical hydrogels were prepared by varying the proportions of 
gelatin solution (GS) and starch dispersions. The compositions of the hydrogels have been 
tabulated in table 1. The hydrogels were prepared by mixing GS and starch dispersions and 
subsequently homogenizing the dispersion at 500 rpm for 30 min at 40 °C. The homogenized 
mixture was then poured into culture bottles and then stored under refrigerated conditions for 
further analysis. Hydrogel made with GS alone served as a control. The MZ-loaded hydrogels 
were prepared in a similar manner such that the final concentration of the drug in the hydrogel 
was 1% (w/v). MZ was dissolved in the GS-starch dispersion mixture during homogenization.  
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Table 1: Composition of Physical hydrogels 
Sample Volume of starch dispersion 
(ml) 
MZ 
(%, w/v) 
GS CS SS BS 
GH 20.0 0 -- -- -- 
CS1 16.0 4.0 -- -- -- 
CS2 12.0 8.0 -- -- -- 
CS3 8.0 12.0 -- -- -- 
SS1 16.0 -- 4.0 -- -- 
SS2 12.0 -- 8.0 -- -- 
SS3 8.0 -- 12.0 -- -- 
BS1 16.0 -- -- 4.0 -- 
BS2 12.0 -- -- 8.0 -- 
BS3 8.0 -- -- 12.0 -- 
GHM 20.0 0 -- -- 1 
CS1M 16.0 4.0 -- -- 1 
CS2M 12.0 8.0 -- -- 1 
CS3M 8.0 12.0 -- -- 1 
SS1M 16.0 -- 4.0 -- 1 
SS2M 12.0 -- 8.0 -- 1 
SS3M 8.0 -- 12.0 -- 1 
BS1M 16.0 -- -- 4.0 1 
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BS2M 12.0 -- -- 8.0 1 
BS3M 8.0 -- -- 12.0 1 
2.3. Microscopic studies 
The microstructure of the hydrogels was studied using inverted phase contrast (Olympus INVI-
TR attached with SONY digital camera EPL-1, USA) and scanning electron microscopy (JEOL, 
JSM-6390, JAPAN). The inverted phase contrast microscopy was carried out by converting the 
physical hydrogels into thin smears.  
2.4. Thermal studies 
The melting point of the hydrogels was determined by drop-ball method as mentioned in the 
previous literature [46]. In short, 2 g of the hydrogels were melted and poured in 10 ml of test 
tubes. The test tubes were incubated for 15 min in a laboratory refrigerator, maintained at 4 ±1 
°C. After refrigeration, a stainless steel (SS) ball (diameter 1/8 inch; weight 130 mg) was placed 
gently on top of the hydrogels. The hydrogels were heated at a rate of 1 °C/min in a melting 
point apparatus. The melting point (Tm) of the hydrogels was noted when the SS ball completely 
submerges [86].  
2.5. pH Measurement 
The pH of the hydrogels was measured using a digital pH meter (EI digital pH meter, model no: 
112, India) [87].  
2.6. Hemocompatibility test 
Hemocompatibility of the hydrogels were determined as per the reported literature [88]. The % 
hemolysis of the blood was calculated as per the equation 1. 
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test Negative
positive Negative
OD OD
Hemolysis
OD OD

 

   (1) 
2.7. In vitro drug release 
The drug release study was carried out using a 2-compartment modified Franz diffusion cell, as 
per the reported literature [89]. In short, accurately weighed 1.5 g of the drug loaded hydrogel 
was loaded in the donor compartment. The donor compartment was lowered towards the receptor 
compartment so as to ensure that the dialysis membrane (attached with the donor compartment) 
was in contact with the receptor fluid (50 ml of DW), kept on stirring at 100 rpm and the 
temperature was maintained at 37 ± 1 °C. The receptor fluid was replaced by fresh DW at regular 
intervals (15 min during first hour and subsequently after 30 min during the next 7 h). The 
samples were then analyzed using UV-visible spectrophotometer (UV-3200, LABINDIA, 
Mumbai, India). 
3. Results and discussion 
3.1. Preparation of physical hydrogels 
The hydrogels were prepared by varying the proportions of GS and starch dispersions. The 
organoleptic properties of the hydrogels have been tabulated in table 2. GH was transparent and 
light brown in color. Incorporation of the starch dispersions within the hydrogels resulted in the 
formation of opaque hydrogels. The colors of the starch incorporated hydrogels were white and 
the whiteness of the hydrogels was higher in hydrogels with higher proportions of starch (figure 
1). The hydrogels had a pleasant odor and were thermo-reversible in nature. They did not show 
flow when kept under refrigerated conditions (figure 1). The hydrogels with higher proportions 
of starch showed flow when kept at RT (room-temperature, 25 C). With the further increase in 
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the proportion of the starch dispersion, there was no formation of the hydrogels. The restrained 
flow of the hydrogels at lower temperatures may be attributed to the formation of ordered 
network arrangements of gelatin molecules [90]. This is due to the presence of α-helical 
structures in gelatin molecules [85]. Incorporation of MZ within the hydrogels neither altered the 
gelation property nor caused any change in the organoleptic properties.  
 
 
 
Table 2: The stability and nature of physical hydrogels 
Sample Result Color ODOUR 
GH/GHM Gel formed Brownish Pleasant 
CS1/CS1M Gel formed Cream Pleasant 
CS2/ CS2M Gel formed Cream Pleasant 
CS3/ CS3M Gel formed White Pleasant 
SS1/ SS1M Gel formed Yellow Pleasant 
SS2/ SS2M Gel formed Cream Pleasant 
SS3/ SS3M Gel formed White Pleasant 
BS1/ BS2M Gel formed White Pleasant 
BS2/ BS3M Gel formed White Pleasant 
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BS3/ BS3M Gel formed White Pleasant 
 
 
Figure 1: The stable physical hydrogels (a) GH, (b) CS1, (c) CS2 , (d) CS3, (e) SS1 (f) SS2, 
(g) SS3, (h) BS1, (i) BS2 and (j) BS3. 
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3.2. Hydrogel morphology 
 
Figure 2: Phase contrst micrographs of hydrogels (a) GH, (b) CS1, (c) CS2 , (d) CS3, (e) 
SS1 (f) SS2, (g) SS3, (h) BS1, (i) BS2 and (j) BS3. 
The microstructures of the hydrogels as visualized under inverted phase contrast microscope 
have been shown in figure 2. The microstructures of the hydrogels have shown the presence of 
phase separated starch inclusions in the form of dark globules in the gelatin continuous matrices . 
The increase in the density of starch inclusions was observed with the increase in starch 
concentrations. This suggested that the phase separation phenomenon was dependent on the 
composition of the hydrogels. An increase in the tendency of the phase separation was observed 
49 
 
with the increase in starch concentration. In general, phase separation is a common phenomenon 
occuring in protein-polysacharide mixtures. Since both gelatin and starch molecules are not 
polyelectrolytes, there are chances of thermodynamic incompatibility which might resulted in the 
segregative phase separation [91]. This might have resulted in the increased self-association of 
the biopolymers [92]. Phase separation has been found to be dependent on the structure and the 
composition of the biopolymers used.  
SS is rich in amylodextrin (linear short chained amylose units) and is devoid of amylopectin. The 
thermal incompatiblity was found to be lower when linear chained carboxyl containing 
polysaccharides were used in the protein-polysaccharide system [91]. Similar results were 
obtained when SS was used for the development of the hydrogels, i.e. SS hydrogels showed 
small starch droplets/inclusions as compared to the CS and BS hydrogels . The presence of larger 
droplets/inclusions in CS and BS hydrogels may be associated with the presence of hyper-
branched polysaccharide units (amylopectin), which lead to the aggregation of polymeric chains 
[93].  
 
3.3. Thermal studies 
The gel-to-sol transition temperature (Tgs) was determined by drop ball method. GH showed 
highest Tgs compared to the other hydrogels. This may be due to the presence of only gelatin 
molecules in GH. With the increase in the concentration of the SS, CS and BS, there was a 
decrease in the Tgs of all the gels. The CS and SS containing gels have shown similar Tgs. The Tgs 
of the BS hydrogels were lower than the CS and the SS hydrogels.  This can be attributed to the 
reduction in the proportion of the gelatin, the biopolymer responsible for incorporating 
50 
 
mechanical strength in the hydrogels. The lower Tgs of the BS hydrogels might be attributed to 
the disruption of starch complexes when heated at higher temperatures. This results in the 
random orientation of the starch molecules [94]. 
Table 3: The Tgs values of the physical hydrogels 
Sample Tgs (°C) 
GH 35.0 ± 1.5 
CS1 32.0 ± 3.5 
CS2 28.0 ± 1.5 
CS3 23.0 ± 1.0  
SS1 33.0 ± 2.5 
SS2 25.0 ± 3.0 
SS3 17.0 ± 2.5 
BS1 27.0 ± 3.0 
BS2 20.0 ± 2.5  
BS3 15.0 ±3.0 
3.4. pH Measurement 
The pHs of the hydrogels were found to be in the range of 5.4 and 6.0. The results suggested that 
the hydrogels may be tried for topical/ transdermal application. 
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Table4: The pH of Hydrogels 
Sample No pH 
GH 5.82 ± 0.72 
CS1 5.91 ± 0.38 
CS2 5.72 ± 0.44 
CS3 5.64 ± 0.63 
SS1 5.75 ± 0.39  
SS2 5.68 ± 0.32  
SS3 5.77 ± 0.63  
BS1 5.41 ± 0.43  
BS2 5.76 ± 0.38  
BS3 5.88 ± 0.32  
 
 
3.5. Hemocompatibility studies 
The hemocompatibility test results of the hydrogels have been tabulated in table 5. The % 
hemolysis of all the samples was found to be < 5%. Hence, the hydrogels may be regarded as 
highly hemocompatible and hence may be tried for various biological applications [86].  
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Table 5: Hemocompatibility studies 
Sample % Hemolysis 
GH 3.21 ± 0.21  
CS1 2.15 ± 0.35  
CS2 1.70 ± 0.43  
CS3 1.12 ± 0.54  
SS1 1.76 ± 0.31  
SS2 1.24 ± 0.28  
SS3 0.69 ± 0.19  
BS1 1.65 ± 0.34  
BS2 1.19 ± 0.32  
BS3 0.64 ± 0.37  
3.6. In vitro drug release studies 
The in vitro drug release profiles of MZ from the hydrogels have been shown in figure 13.The 
rate of the release of the drug was found to be dependent on the composition of hydrogels. GH 
showed ~98% of the cumulative percent drug release (CPDR). Amongst the starch hydrogels, CS 
hydrogels have shown better release rate as compared to BS and SS hydrogels. The physical 
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nature of the hydrogels might have affected the CPDR of the drug from the hydrogels [86, 95]. 
The CPDR of MZ from the starch hydrogels was in the range of 70 % and 80 %. In general, with 
the increase in the starch concentration, there was a reduction in the release rate of MZ. The 
release of the drug from the hydrogels followed Higuchian kinetics. This indicated that the 
hydrogels acted as a planar matrix for the drug molecules and the release of the drug from the 
matrices was diffusion controlled. The Fickian value (n) was calculated from Krossmeyer-
Peppas (KP) model. The „n‟ values were in the range of 0.45 and 0.85 thereby suggesting a non-
Fickian diffusion of the drugs from the hydrogels [96-97]. 
 
Figure 13: In vitro drug release profiles of (a) GHM, (b) CSM, (c) SSM and (d) BSM gels. 
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4. Conclusion 
Gelatin-starch based physical composite hydrogels were developed by phase-separation 
technique. The phase separation of starch inclusions in the rich gelatin phase was confirmed by 
microscopic techniques. The mechanical properties of the hydrogels could be varied by altering 
the composition of the hydrogels. The drug loaded hydrogels showed good antimicrobial 
properties against both E. coli and B. subtilis. The hydrogels were found to be hemocompatible 
in nature. Based on the preliminary studies, the developed formulations may be tried as drug and 
nutraceutical delivery vehicles in pharmaceutical and food industries. 
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